Brief: Panbela Provides Business Update And Reports Q1 2023 Financial Results
04/05/2023 22:15
May 4 (Reuters) - Panbela Therapeutics Inc PBLA.O :
* PANBELA PROVIDES BUSINESS UPDATE AND REPORTS Q1 2023
FINANCIAL
RESULTS
* QTRLY NET LOSS PER SHARE $0.65
* TOTAL CASH WAS $5.2 MILLION AS OF MARCH 31, 2023
* Q1 EARNINGS PER SHARE VIEW $-0.54 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX3JkZnN
Further company coverage: PBLA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Panbela Therapeutics
See all newsBrief: Panbela Therapeutics Announces Third Independent Safety Review Of Phase 3 Aspire Clinical Trial DSMB Recommended Continuation With No Trial Modification
Brief: Nasdaq Notifies Panbela Therapeutics Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
Brief: Panbela Announces Pricing of Approximately $9 Mln Public Offering
U.S. STOCKS ON THE MOVE-Fisker, Best Buy, NuStar Energy
Brief: Panbela Therapeutics Announces Exercise Of Warrants And Issuance Of New Warrants